These pages are work in progress. Please add comments if you want. If you have material to submit send them to me via admin@wmsurgeons.com
|
Search:
Advanced search
|
Browse by category:
|
Contact Us |
Entero Cutaneous fistula |
|||||
Entero Cutaneous Fistula
Source: Surgery of the anus, recrum and colon. Keighley and Williams. Second edition Vol2
General statement: Patients survive following huge investments in time and involvement of a team who are able to provide specialist advice. It is NOT a quick fix will cure approach
Classification
Aetiology
Apply the surgical sieve.
Clinically
Often SIRS develops first. Then skin shows signs of abscess formation then pus discharges followed by faecal contents.
Considerations:
Management
How would you therefore manage a fistula?
Principles
1) Resuscitate and control fistula discharge
2) Elimination of sepsis
3) Parental nutrition
4) Rehabilitation and ambulation
5) Define the anatomy of the fistula
6) Definitive surgical procedure if indicated
7) This is a TEAM approach
Resuscitate and control fistula discharge
NGT
Catheter
Input /output charts
Correct electrolyte imbalance
Somatostatin analogues – octreotide
Elimination of sepsis
Peritonitis – Laparotomy +/- laparostomy
Stoma
Pus – percutaneous drainage
Parental nutrition
50kcal/kg/day = 3500kcal /day
400mg/kg/day Nitrogen
For proximal fistulas – consider distal feeding via jejunostomy
Rehabilitation and ambulation
Psychological support and physio
Define the anatomy of the fistula
Is there bowel continuity?
Which bit is involved?
Likely pathology?
Distal obstruction?
CT / enemas/ follow throughs / MRI
Definitive surgical procedure if indicated
· TB – rifampicin, isonizid / ethambutol
o If no improvement after 4-6 weeks treatment – resection
· Actinomycosis – erythromycin!
· Crohns –
o Medical management
European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns treatment of active disease.
BSG guidelines 2005 do not advocate the use of Infliximab in fistulating crohns disease…..However NICE has issued guidance on the use of Infliximab in 2002
Patients who have severe active Crohn's disease. These patients will already be in very poor general health with weight loss and
sometimes fever, severe abdominal pain and usually frequent (3–4
or more) diarrhoeal stools daily. They may or may not be
developing new fistulae or have extra-intestinal manifestations of
the disease. This clinical definition normally corresponds to a
Crohn’s Disease Activity Index (CDAI) score of 300 or more and
a Harvey-Bradshaw Index of 8/9 or above
They refer to the ACCENT II Trial:
In complex peri anal fistulating crohns....2/3 of fistulae will show response in 3/12 Of these 33% closed with continuing maintainance therapy 20% closed with placebo Put another way 1/3 will not respond at all, and of those that do respond only do partially and 2/3 of these will have a persistent fistula at 1 year during the maintainance period ON treatment. Surgery for Crohn’s
Given the above only 10-20% will close with medical managemtn alone. Surgery to excise the effected segment is the only treatment likely to fully cure the patient.
· Diverticular disease
o Surgery
· Cancer
o Palliative surgery
· Radiation
o Remember only 14% close on their own
o Resect to normal bowel and anastamose
· Post operative
o Wait and then wait some more
o Close at 6 months if possible. |
|||||